- Email: [email protected]
OWA Leadership Conference To Be Held in San Antonio
OWA Leadership Conference To Be Held in San Antonio APhA's Office of Women's Affairs (OWA) will conduct an eight-hour Leadership Conference in San Antonio February 16-17, beginning at 1 pm Saturday and concluding at noon on Sunday. Pharmacists planning to attend the Annual Meeting who wish to be on hand a day early to participate in this first OWA conference will want to arrange their itinerary accordingly. The Leadership Conference, which responds to the recommendations of the APhA Task Force on Women in Pharmacy, is being made possible by grants from McNeil Consumer Products Company, McNeil Pharmaceutical, and Ortho Pharmaceutical Corporation-three of the Johnson & Johnson family of companies. The conference itself is directed to all pharmacists-but especially women pharmacists-who are interested in identifying and developing skills which will enhance their leadership capability. Conference goals are to: • Identify the characteristics of an effective leader; • Help pharmacists develop skills which will help them become more effective leaders; • Assist pharmacists in identifying ways to demonstrate these skills so that they will function more effectively within their work and business settings as well as in their organiza tions. The conference includes a Saturday evening reception which will give registrants the opportunity to "network" with their colleagues, and a Sunday breakfast featuring a "Meet APhA Leaders" session. The sessions will be coordinated by management consultant Debra A. Smith, who received high marks for her session on "Women in Pharmacy Management" presented at APhA's 1984 Annual Meeting in Montreal. As a speaker and trainer, Smith travels to some 140 cities a year to conduct seminars, and her
32
Management Consultant Smith
clients include many prestigious corporations and institutions. Smith will be supported by a faculty of leaders in pharmacy. Gloria "J 0" Floyd, an outstanding nurse educator, will present the keynote_
address and participate in the workshop sessions. Professor Kenneth Kirk, from the Pharmacy Administration Division of the University of Texas College of Pharmacy, will assist with the workshops, evaluate the sessions, and summarize the conference at the closing session. Participants can earn eight hours of Continuing Education credit at the conference. The registration fee ($60 for APhA members or $90 for non-APhA members) includes eight hours of intensive training with opportunities to interact with leaders, to demonstrate leadership skills and to learn how to work with people-leaders and followers. Registration will be limited to 300 pharmacists and will be closed December 1. To register, send your name and address along with the fee to: APhAIOWA 2215 Constitution Ave. NW Washington, DC 20037 Please make checks payable to APhAIOWA.
- Drug News (continued from page 31)
often an early sign of certain colorectal diseases such as colitis, diverticulitis, and colorectal cancer. The test kit contains color-coded instructions and is easy for patients to use. The Hemoccult professional test kit has been on the market for more than 10 years. The Hemoccult Home Test is the self-test version of Hemoccult II, marketed by SmithKline Diagnostics to the health care community. The new home kit allows the patient to complete the test and also read the results in the privacy of the home. Lotrisone Cream (Schering Laboratories) is a dual-action topical antifungal product for the specific treatment of tinea cruris, tinea pedis,
and tinea corporis. Available only by prescription, the cream contains clotrimazole, an antifungal, and betamethasone dipropriona te, a corticosteroid. In double-blind trials with 600 patients, Lotrizone was evaluated against its two component ingredients. Lotrisone demonstrated significantly more rapid therapeutic effects than either constituent ingredient alone. Also, more of the patients in the study were cured of their condition. Side effects were minimal. Lotrisone Cream has a smooth, nonstaining, hydrophilic emollient base. It should be massaged gently into the affected areatwice a day for two weeks for tinea cruris or tinea corporis, and twice a day for four weeks for tinea pedis.
American Pharmacy Vol. NS24, No. 10, October 1984/660
32
Management Consultant Smith
clients include many prestigious corporations and institutions. Smith will be supported by a faculty of leaders in pharmacy. Gloria "J 0" Floyd, an outstanding nurse educator, will present the keynote_
address and participate in the workshop sessions. Professor Kenneth Kirk, from the Pharmacy Administration Division of the University of Texas College of Pharmacy, will assist with the workshops, evaluate the sessions, and summarize the conference at the closing session. Participants can earn eight hours of Continuing Education credit at the conference. The registration fee ($60 for APhA members or $90 for non-APhA members) includes eight hours of intensive training with opportunities to interact with leaders, to demonstrate leadership skills and to learn how to work with people-leaders and followers. Registration will be limited to 300 pharmacists and will be closed December 1. To register, send your name and address along with the fee to: APhAIOWA 2215 Constitution Ave. NW Washington, DC 20037 Please make checks payable to APhAIOWA.
- Drug News (continued from page 31)
often an early sign of certain colorectal diseases such as colitis, diverticulitis, and colorectal cancer. The test kit contains color-coded instructions and is easy for patients to use. The Hemoccult professional test kit has been on the market for more than 10 years. The Hemoccult Home Test is the self-test version of Hemoccult II, marketed by SmithKline Diagnostics to the health care community. The new home kit allows the patient to complete the test and also read the results in the privacy of the home. Lotrisone Cream (Schering Laboratories) is a dual-action topical antifungal product for the specific treatment of tinea cruris, tinea pedis,
and tinea corporis. Available only by prescription, the cream contains clotrimazole, an antifungal, and betamethasone dipropriona te, a corticosteroid. In double-blind trials with 600 patients, Lotrizone was evaluated against its two component ingredients. Lotrisone demonstrated significantly more rapid therapeutic effects than either constituent ingredient alone. Also, more of the patients in the study were cured of their condition. Side effects were minimal. Lotrisone Cream has a smooth, nonstaining, hydrophilic emollient base. It should be massaged gently into the affected areatwice a day for two weeks for tinea cruris or tinea corporis, and twice a day for four weeks for tinea pedis.
American Pharmacy Vol. NS24, No. 10, October 1984/660